{"id":"W2402339939","doi":"","title":"State of Pharmaceutical Research and Development in Canada. Bioequivalence of Drug Products with Special Characteristics. Report of the February 13-14, 1998 Canadian Society for Pharmaceutical Sciences Symposium.","year":2000,"lang":"en","type":"other","venue":"PubMed","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Bioequivalence; Pharmaceutical sciences; Pharmaceutical drug; Drug; Medicine; Pharmacology; Pharmacokinetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003674842,0.0007311573,0.0004668316,0.004960903,0.004446796,0.00260797,0.001686951,0.001896206,0.01508129],"category_scores_gemma":[0.005287806,0.0006173183,0.0005069468,0.007757269,0.001365187,0.0009996012,0.0006831644,0.001766863,0.002880603],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0487363,"about_ca_system_score_gemma":0.1988308,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9819983,"about_ca_topic_score_gemma":0.9881882,"domain_scores_codex":[0.9954619,0.0001853556,0.0002058215,0.0001494278,0.00337679,0.0006207204],"domain_scores_gemma":[0.987934,0.001000035,0.0007533181,0.0001418271,0.008582159,0.001588624],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003504278,0.00009493651,0.004570988,0.0007272177,0.00002324519,0.0001636355,0.0002004787,0.000451543,0.001370132,0.006883088,0.8238827,0.1612817],"study_design_scores_gemma":[0.00005943135,0.00004623106,0.03326327,0.0003640716,0.00005953727,0.00006733427,0.0002166065,0.0004607867,0.002381305,0.0008134982,0.9622186,0.00004943435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.01525108,0.3881748,0.003529651,0.1117436,0.007702267,0.0007224609,0.08438049,0.0009587926,0.3875369],"genre_scores_gemma":[0.1839273,0.2805254,0.01587691,0.01620418,0.001176764,0.0003190341,0.03816327,0.0003428883,0.4634643],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9963251,"threshold_uncertainty_score":0.3536083,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07050487294175384,"score_gpt":0.3214421824816812,"score_spread":0.2509373095399274,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}